Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Gemcitabine

A nucleoside analogue of deoxycytidine carrying two fluorine atoms, synthesised in the early 1980s and approved in 1995; it is a chemotherapy drug for cancers of the pancreas, lung, bladder, ovary and breast. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?It was created in chemist Larry Hertel's laboratory as an antiviral, but preclinical tests showed it could kill leukaemia cells: so it changed course and became an anticancer drug.

GemcitabineGo to the active ingredient →
GemcitabineActive ingredientGemcitabineCat. No. P-G023-001CAS 95058-81-4

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.